Global Cell Culture Market
Global Cell Culture Market By Product (Consumables, Equipment), By Application (Biopharmaceutical Production, Drug Development, Diagnostics, Tissue Culture & Engineering, Cell & Gene Therapy, Toxicity Testing, Others), By End-User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Academic and Research Institutions, Others) And By Geography – Covid-19 Impact Analysis, Post Covid Analysis, Opportunities, Trends And Forecast From 2021 to 2034
The global Cell Culture market was valued at $26.28 Billion in 2023 and is anticipated to grow at a CAGR of 13.32% from 2024 to 2034. This growth is attributed to several macro and microeconomic factors such as
Growing Demand for BiopharmaceuticalsThe escalating demand for biopharmaceuticals is a significant driver of the global cell culture market. Biopharmaceuticals, derived from living organisms, offer numerous advantages over traditional small-molecule drugs, including improved efficacy, reduced side effects, and targeted therapies. To produce these complex biological molecules, cell culture technology plays a crucial role, providing a controlled environment for cultivating cells and producing the desired biopharmaceuticals. As the demand for innovative treatments for various diseases, such as cancer, autoimmune disorders, and infectious diseases, continues to grow, so does the reliance on cell culture technology to meet this increasing need.
Further several factors restraining the market growth include
High Costs of Cell Culture ProductsOne of the primary challenges facing the global cell culture market is the high cost associated with cell culture products. These costs include the expenses for specialized cell culture media, growth factors, sera, and other reagents. Additionally, maintaining aseptic conditions requires sophisticated laboratory equipment, such as incubators, biosafety cabinets, and cell counters, which can be expensive to purchase and operate. These high costs can significantly impact the affordability of cell culture technologies, particularly for smaller research institutions and developing countries, limiting their accessibility and hindering the growth of the market.
Advancements in 3D cell culture technologies and collaborations and alliances in the Cell Culture market are expected to generate higher avenues during the forecast period.In the wake of the COVID-19 pandemic, supply chain disruptions have led to supply shortages or lower demand in the Cell Culture market. The pandemic has caused a decline in new orders and a corresponding decrease in Applicationion.
This section will analyze how COVID-19 has impacted supply chains, leading to shortages and lower demand for Cell Culture.
In terms of COVID-19 impact, the Cell Culture market report also includes the following data points:Impact on Cell Culture market size
Operating Weights Trend, Preferences, and Budget Impact
Regulatory Framework/Outdoor Policies
Key Players' Strategy to Tackle Negative Impact/Post-COVID Strategies
Opportunity in the Cell Culture market
Key Insight in the report:The global Cell Culture market report covers an executive summary, market dynamics, COVID impact & post-COVID scenario, market size and forecast, competitive intelligence, market positioning, and Applications.
Our report covers extensive competitive intelligence which includes the following data points:Business Overview
Business Segment Data
Financial Data
Application Segment Analysis and Specification
Recent Development and Company Strategy Analysis
SWOT Analysis
Cell Culture Market Segmentation:Product
Consumables
Sera
Fetal Bovine Sera (FBS)
Adult Bovine Sera (ABS)
Other Animal Sera
Reagents
Growth Factors
Supplements
Buffers & Chemicals
Cell Dissociation Reagents
Cryoprotective Agents
Other Reagents
Media
Serum Free Media
Classical Media & Salts
Stem Cell Culture Media
Specialty Media
Chemically Defined Media
Others
Equipment
Bioreactors
Storage Equipment
Other Equipment
Application
Biopharmaceutical Production
Drug Development
Diagnostics
Tissue Culture & Engineering
Cell & Gene Therapy
Toxicity Testing
Other
End-User
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Academic and Research Institutions
Others
Region/ Countries Covered:North America
US
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
BeNeLux
Russia
Rest of Europe
Asia Pacific
China
Japan
Australia
India
South Korea
Thailand
Indonesia
Malaysia
Rest of Asia Pacific
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
UAE
Egypt
South Africa
Rest of Middle East & Africa
Key Players Analyzed in the Report:Thermo Fisher Scientific Inc
Danaher Corporation
Sartorius AG
Merck KGaA
Corning Incorporated
FUJIFILM Corporation
BD
Eppendorf SE
Lonza
Getinge AB